Position in BCAB
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$53,069
-$57,889 QoQ
Shares Held
12,819
-98.1% QoQ
Ownership
0.769%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 21 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,870,628,057 across 520 Biotechnology names. BCAB ranks #474 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in BCAB
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $53,069 | 12,819 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $110,958 | 689,182 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $284,186 | 500,328 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $340,705 | 495,211 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $194,933 | 492,259 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $166,305 | 479,268 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $248,217 | 419,998 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $713,178 | 405,215 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $554,253 | 404,565 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $3,174,906 | 922,938 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $2,224,036 | 904,080 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,448,600 | 852,118 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,493,228 | 831,076 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,006,163 | 375,434 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,906,450 | 352,297 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,087,924 | 271,159 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $515,513 | 180,882 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,055,445 | 211,089 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $5,680,804 | 289,394 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $5,553,178 | 188,627 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $8,617,845 | 203,347 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $9,911,359 | 194,952 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $593,100 | 17,439 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||